Several studies have indicated that benzodiazepines influence immunity in both animals and humans. As these medications are commonly utilized by and for psychiatric patients, investigation of psycho-immunologic relationships in human psychiatric disorders may be confounded by use of these medications. Method: We undertook an investigation for possible effects of recent benzodiazepine use on depression-immune relationships by comparing 43 patients with current major depressive disorder (MDD) who used benzodiazepines in the week prior to study to 27 patients with current MDD but no use of benzodiazepines in the past month. Both functional and ennumerative measures were investigated. Results: We found no differences in absolute numbers of lymphocytes or the lymphocyte and NK functional measures. We did find differences between these two groups in the percentage of lymphocytes and of NK cells. Upon further analysis, controlling for symptom severity, these differences were shown to not be independently predicted by benzodiazepine use. Conclusion: Immune measures in subjects with current MDD and recent benzodiazepine use did not differ from those without such recent use. Therefore, such recent use is unlikely to confound PNI results.
INTRODUCTION
A significant body of literature has supported the hypotheses that depressive disorder is associated with differences in various aspects of immunity (Herbert & Cohen, 1992) . However, psycho-immunologic relationships in humans are complex and difficult to study due to the many confounding factors which may obscure relationships of interest. This has led to investigations of possible confounding variables. As we and others have previously reported, the use psychotropic medications can be one such confound (Andreoli et al., 1993; Ferguson et al., 1978; Fu et al., 1977) .
Benzodiazepines are among the most frequently prescribed psychotropic medications (Gold et al., 1995) . They are used in many psychiatric disorders as well in a number of medical conditions associated with anxiety, irritability, and dysphoria. They are frequently prescribed by non-psychiatrists or otherwise obtained by patients with these symptoms prior to their coming to psychiatric attention. The issue of potential benzodiazepine/immune system relationships is therefore particularly relevant in clinical investigations of psycho-immune relationships.
Recent reports have indicated that such relationships may not be negligible (Drugan, 1994) . Receptors for benzodiazepines consist of two basic types: the central type located within the brain and the peripheral type which are located in many cell and tissue types (Squires & Baestrup, 1977) . Specifically, receptors for benzodiazepines have been demonstrated on immunocytes (Canat et al., 1993; Cahard et al., 1994) and benzodiazepines have been found to affect immune activity (Shanks et al., 1994; Irwin et al., 1993; Ramseier et al., 1993; Bessler et al., 1991; Petitio et al., 1989; Schlumpf et al., 1989; Ruff et al., 1985; Wang et al., 1984) .
Other studies have also suggested that benzodiazepines may influence immunity. In patients with anxiety disorder, the density of benzodiazepine receptors on lympho-
